Pulmonary vascular pathology forms an important challenge in daily clinical practice; pulmonary embolism (PE) is the third leading cause of cardiovascular mortality in North America and is responsible for 510% of all in-hospital deaths. Furthermore, the diagnosis of PE remains one of the most difficult problems confronting clinicians. Timely diagnostic testing must be performed to enable the initiation of antithrombotic therapy for patients proven to have this condition while avoiding the risks of anticoagulation for patients without PE. The widespread adoption of right heart catheterisation.
Lung transplantation is a treatment option for selected patients who are not responding to maximal medical therapy, or for whom no effective medical therapy exists. This Monograph provides a comprehensive guide to the recent advances in lung transplantation, and includes coverage of donor selection, immunosuppression, infectious and noninfectious complications, and management of bronchiolitis obliterans syndrome and post-transplant lymphoproliferative disease emerging after lung transplantation.
Diseases of the chest are numerous and a multidisciplinary approach by the chest physician and thoracic surgeon is often required, not only in the management of chest malignancies, but also in the treatment of non-neoplastic disorders of the chest. Furthermore, many advances and improvements are put forward in the overall management of patients with advanced lung disease; besides lung transplantation, volume reduction surgery is reported as an alternative surgical option for emphysema patients which may delay, or even preclude the need for transplant. Management of suppurative lung and pleural.
Pulmonary vascular pathology forms an important challenge in daily clinical practice; pulmonary embolism (PE) is the third leading cause of cardiovascular mortality in North America and is responsible for 510% of all in-hospital deaths. Furthermore, the diagnosis of PE remains one of the most difficult problems confronting clinicians. Timely diagnostic testing must be performed to enable the initiation of antithrombotic therapy for patients proven to have this condition while avoiding the risks of anticoagulation for patients without PE. The widespread adoption of right heart catheterisation.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.